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How congenital defects causing genome instability can result in the pleiotropic symptoms reminiscent of aging but in a
segmental and accelerated fashion remains largely unknown. Most segmental progerias are associated with
accelerated fibroblast senescence, suggesting that cellular senescence is a likely contributing mechanism. Contrary to
expectations, neither accelerated senescence nor acute oxidative stress hypersensitivity was detected in primary
fibroblast or erythroblast cultures from multiple progeroid mouse models for defects in the nucleotide excision DNA
repair pathway, which share premature aging features including postnatal growth retardation, cerebellar ataxia, and
death before weaning. Instead, we report a prominent phenotypic overlap with long-lived dwarfism and calorie
restriction during postnatal development (2 wk of age), including reduced size, reduced body temperature,
hypoglycemia, and perturbation of the growth hormone/insulin-like growth factor 1 neuroendocrine axis. These
symptoms were also present at 2 wk of age in a novel progeroid nucleotide excision repair-deficient mouse model
(XPDG602D/R722W/XPA/) that survived weaning with high penetrance. However, despite persistent cachectic dwarfism,
blood glucose and serum insulin-like growth factor 1 levels returned to normal by 10 wk, with hypoglycemia
reappearing near premature death at 5 mo of age. These data strongly suggest changes in energy metabolism as part
of an adaptive response during the stressful period of postnatal growth. Interestingly, a similar perturbation of the
postnatal growth axis was not detected in another progeroid mouse model, the double-strand DNA break repair
deficient Ku80/ mouse. Specific (but not all) types of genome instability may thus engage a conserved response to
stress that evolved to cope with environmental pressures such as food shortage.
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Introduction
Congenital defects in genome stability-promoting mecha-
nisms such as DNA repair often lead to elevated cancer
predisposition and/or the accelerated appearance of some
but not all characteristics (‘‘segments’’) observed in natural
aging [1]. Among these so-called segmental progerias, differ-
ent defects lead to the acceleration or exaggeration of
different segments of aging. Typical examples include
Werner syndrome, in which diabetes, osteoporosis, and
increased cancer incidence are observed, and Cockayne
syndrome, characterized by neurological dysfunction and
cachectic dwarﬁsm. Although the causative genetic defects of
many progerias are known, the molecular mechanisms
underlying pleiotropic disease symptoms remain elusive and
their relevance to normal aging controversial [2]. However,
because cultured ﬁbroblasts from almost all reported mouse
models of segmental progeria (as well as many of the
corresponding human progerias) exhibit limited proliferative
capacity [3], cell-based mechanisms including premature
senescence and enhanced apoptosis have emerged as strong
candidates underlying pleiotropic disease symptoms [4,5].
The evolutionarily conserved nucleotide excision repair
(NER) pathway removes helix-distorting DNA damage (such
as UV lesions) in a complex ‘‘cut and patch’’ mechanism.
Inborn NER defects can lead to the skin cancer syndrome
xeroderma pigmentosum (XP) or the segmental progerias
Cockayne syndrome (CS) and trichothiodystrophy (TTD) [6].
An increase in the mutation rate caused by defects in one of
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at least seven different NER proteins (XPA–XPG) explains the
cancer predisposition in XP [7]; each of these proteins
participates in lesion removal anywhere in the genome
(global genome NER). In contrast, how alterations in any of
ﬁve NER-associated proteins (XPB, XPD, XPG, CSA, and CSB)
can cause progeria remains largely obscure. Current genetic
evidence points to a link with defective transcription-coupled
repair [8–11], a subpathway of NER that speciﬁcally removes
lesions on the transcribed strand of active genes that
interfere with transcription, thus promoting cellular survival
from DNA damage [12,13].
The XPD gene, encoding a helicase subunit of the
transcription/NER-associated transcription factor II H com-
plex, is unique amongst NER genes in that different point
mutations are associated with cancer (XP), progeria (TTD), or
a combination (XP combined with Cockayne syndrome
[XPCS] or trichothiodystrophy [XPTTD]) [8,14,15]. Although
the hallmark feature of TTD, brittle hair, is not observed in
CS or XPCS, the neurodevelopmental features of the diseases
are similar [16,17]. In most cases these features include (i)
normal in utero development followed by postnatal growth
failure in the ﬁrst year (including reduced postnatal brain
growth [18]); (ii) progressive gait abnormalities caused by a
combination of cerebellar ataxia, joint contractures, spastic-
ity, and frequent kyphosis; (iii) sensorineural hearing loss; (iv)
progressive loss of subcutaneous fat (cachexia) yielding an
‘‘aged’’ appearance; and (v) the conspicuous lack of (skin)
cancer predisposition despite sun sensitivity due to a cellular
UV repair defect [16,17].
We mimicked point mutations found in human TTD
(XpdTTD) and XPCS (XpdXPCS) patients in the mouse and
reported phenotypic overlap between homozygous mutant
animals and the corresponding human syndromes [9,10].
Crossing mutant Xpd animals allowed us to address the effects
of compound heterozygosity, or the presence of two different
mutant alleles of the same gene, on disease symptoms.
Compound heterozygosity between XpdTTD and XpdXPCS
alleles surprisingly ameliorated developmental delay and
age-related premature cachexia and kyphosis associated with
each homozygous mutant mouse model as well as the
cutaneous abnormalities speciﬁc to the TTD model [19].
Exacerbation of the repair defect by Xpa ablation, on the
other hand, results in a much more severe phenotype
including dramatic postnatal growth retardation, progressive
cerebellar ataxia, lack of subcutaneous fat, and death around
weaning in several of these mouse models (e.g., XPCS/XPA,
TTD/XPA, and CSB/XPA) [9,20,21]. We refer to the above
segmental progeroid phenotypes as ‘‘progeroid NER syn-
drome.’’ Here, we tested the ability of compound hetero-
zygosity at the Xpd locus in an XPA-deﬁcient background
(XpdTTD/XPCS/Xpa/) to ameliorate the severe symptoms
of progeroid NER syndrome associated with the correspond-
ing double homozygous (XpdTTD/TTD/Xpa/ and XpdXPCS/XPCS/
Xpa/) animals.
Results
XPD Compound Heterozygotes in an XPA-Deficient
Background
A comparison amongst the subset of single and combined
NER defects resulting in a severe segmental progeroid
phenotype is presented in Table 1. Intercrossing of Xpdþ/TTD/
Xpa/ and Xpdþ/XPCS/Xpa/ animals resulted in double
homozygous XpdTTD/TTD/Xpa/ and XpdXPCS/XPCS/Xpa/ mu-
tant mice (subsequently referred to as TTD/XPA and XPCS/
XPA animals, respectively) as well as compound hetero-
zygous XpdXPCS/TTD/Xpa/ (CH/XPA) mice. Expected at a
Mendelian frequency of 25%, XPCS/XPA and TTD/XPA
mice were instead observed at 15% and 5%, respectively,
upon genotyping at postnatal day 9–10. CH/XPA animals
were present at 20%, closer to the expected ratio of 25%.
XpdWT/XPCS or TTD/Xpa/ (subsequently referred to as XPA)
animals were used as controls in subsequent experiments,
because XPA deﬁciency on its own has no or relatively
minor effects on growth, development, or fecundity [22,23].
Although indistinguishable from control littermates after
birth, indicative of normal in utero development, CH/XPA
mice were visibly smaller than XPA littermates by 2 wk of age
(Figure 1A and unpublished data), similar to XPCS/XPA and
TTD/XPA mice [9,21]. CH/XPA mice also displayed abnormal
gait and tremors (unpublished data) consistent with cerebel-
lar ataxia as previously observed in several other progeroid
NER-deﬁcient mouse models (Table 1). However, unlike
XPCS/XPA and TTD/XPA, CH/XPA mice survived the
stressful weaning period with high penetrance (;80%),
reaching an average body weight about half that of littermate
controls (Figure 1A).
Despite their small size, we consistently noted unusual
daytime feeding behavior in CH/XPA mice, prompting an
investigation into their average daily food intake. At 6 wk of
age, mutant mice consumed 23% more food per gram of
body weight than littermate controls (p¼ 0.001; Figure 1B). In
a repeat experiment with 7-wk-old mice from a different
litter, CH/XPA animals ate 12% more than littermate
controls (p ¼ 0.09). In both cases, food consumption per
gram of body weight was similar between CH/XPA mice and
younger (3- to 5-wk-old) control mice having similar weights
but growing faster (Figure 1B and unpublished data). We
conclude that food consumption corrected for body weight in
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Synopsis
Oxidative damage to cellular components, including fats, proteins,
and DNA, is an inevitable consequence of cellular energy use and
may underlie both normal and pathological aging. Calorie restriction
delays the aging process and extends lifespan in a number of lower
organisms including rodents. Inborn defects in the postnatal growth
axis resulting in dwarfism can also extend lifespan. Both may
function via overlapping pathways impacting on energy metabo-
lism. Here, we report a novel DNA repair-deficient mouse model
with symptoms of the related premature aging disorders Cockayne
syndrome and trichothiodystrophy, namely reduced fat deposits,
neurological dysfunction, failure to thrive, and reduced lifespan.
Surprisingly, we also observed traits usually associated with
extended longevity as found in calorie restriction and dwarfism,
including reduced blood sugar and reduced insulin-like growth
factor-1. These characteristics were present at 2 wk of age, that is,
during the period of rapid postnatal development, but returned to
normal by sexual maturation at 10 wk. Furthermore, they were
absent altogether in another premature aging mouse model with a
distinct DNA repair defect. Specific types of unrepaired DNA damage
may thus elicit a preservative organismal response affecting energy
metabolism that is similar to the one that evolved to cope with the
stress of food shortage.
CH/XPA mice was equal to or greater than that of littermate
controls and thus does not explain their smaller size.
Furthermore, at 10 wk of age, CH/XPA mice weighed on
average 71% of littermate XPA controls and had a cachectic
appearance. Corrected for body weight, white adipose tissue
deposits were on average 48% of those of controls (peri-
gonadal 41%, mesenteric 52%, adrenal 37%, and subcuta-
neous 57%; overall p ¼ 0.01). Interestingly, however,
interscapular brown adipose tissue deposits corrected for
body weight were similar between CH/XPA mice and
littermate controls at 10 wk of age. Together these data
suggest that CH/XPA mice differ from control mice in either
the extraction or use of energy from their food.
Between 4 and 6 mo of age, we observed a rapid and
general decline in the overall condition of CH/XPA mice.
Prior to sacriﬁce due to poor health status, mice were on
average 56% of littermate weight and increasingly cachectic,
with white adipose tissue corrected for body weight on
average 43% of that of controls (perigonadal 43%, mesen-
teric 32%, adrenal 20%, and subcutaneous 63%; overall p ¼
0.02) and also reduced interscapular brown adipose tissue
(62% of control, p ¼ 0.01). This decline was accompanied by
other progeroid features, including disturbed gait, frequent
loss of balance, and kyphosis (Figure 1C; Video S1). Kaplan-
Meier survival plots revealed a signiﬁcant difference between
CH/XPA mice and XPA littermate controls (log-rank p, 0.01)
(Figure 1D). Mortality was observed primarily at two points,
the ﬁrst around weaning (approximately 1 mo of age) and the
second around 5 mo of age. Mean lifespan was approximately
5 mo, which is proportional to the percent lifespan of the
related human progeria, CS [16]. Thus, among the reported
progeroid NER mouse models summarized in Table 1, this
mutant is unique in its ability to reach adulthood with high
penetrance despite ataxia and cachectic dwarﬁsm.
Accelerated Fibroblast Senescence Undetected in Multiple
Progeroid NER Syndromes
Among NER-deﬁcient mouse models for which cellular
growth parameters have been reported, an inverse correla-
tion appears to exist between cellular proliferative capacity
in vitro and progeroid features in vivo. For example, primary
mouse embryonic ﬁbroblasts (MEFs) from Xpg/ [24] and
Ercc1/ [25] embryos undergo premature senescence when
cultured under atmospheric (;20%) oxygen tension. XPA
MEFs, on the other hand, have normal proliferative capacity
[26], and the corresponding animals, despite their NER
deﬁciency, lack profound symptoms of progeroid NER
syndrome [23].
We tested this correlation in XPD/XPA MEFs by measuring
proliferation in log-phase cultures at atmospheric (20%)
oxygen tension as well as low (3%) oxygen tension, in which
cellular senescence is rescued in wild-type (WT) MEFs [26].
Despite the severe progeroid symptoms in XPCS/XPA and
TTD/XPA mice in vivo, we found no difference in the long-
term proliferative capacity of XPCS/XPA or TTD/XPA MEFs
in vitro relative to control or single homozygous mutant
littermate controls (Figure 2A and 2B). We also tested MEFs
from another severely affected progeroid NER model, CSB/
XPA (Table 1), and found no difference between control,
single, or double homozygous mutant MEFs (Figure 2C). As a
positive control, Ercc1/ MEFs (n ¼ 4) displayed reduced
proliferative capacity versus heterozygous or WT controls (n
¼ 4) at 20% oxygen tension (unpublished data) as previously
reported [25].
In order to see if this unexpected lack of premature cellular
senescence extended to cells prepared from adult animals or
to another cell type, we tested the proliferative capacity of
dermal ﬁbroblasts prepared from the tails of 10-wk-old CH/
XPA mice and erythroblasts prepared from embryonic day
13.5 fetal livers. Relative to XPA control littermates, no
proliferative defects were observed in either cell type (Figure
2D and 2E). We further tested erythroblasts from double
mutant CSB/XPA as well as single mutant CSB and XPA fetal
livers and found no genotype-speciﬁc proliferative differ-
ences (Figure 2F).
Finally, we tested hypersensitivity of MEFs to acute
oxidative stress induced by ionizing radiation, paraquat,
and tert-butyl hydroperoxide. Similar to Xpg/MEFs [24,27],
we found no signiﬁcant differences between any of the
genotypes (Figure 2G and unpublished data). As a control, all
single and double homozygous mutants tested were hyper-
sensitive to UV-C, consistent with their NER deﬁciencies
(Figure 2G and unpublished data). In conclusion, it is unlikely
that premature senescence or cell death observed in
Table 1. Characteristics of Progeroid NER Syndrome in Mice
Genotype DNA Repair
Defect
Postnatal
Growth Defect
Progressive Neurological
Dysfunction
Lifespan Additional
Pathology
Xpg/ [24,28] NER/TCR Yes Cerebellar ataxia ;2–3 wk Undeveloped small intestines
XpgD811stop (D360) [56] NER/TCR Yes Slightly less severe than Xpg/ 22/24 within 30 d Undeveloped small intestines
XpgDex15jXpa/ [27] NER/TCR Yes n.d. 23/25 within 30 d n.d.
Xpa/jXpdTTD/TTD [21] NER/TCR Yes Ataxia 10/12 within 22 d;
survivors 4, 12 mo
Cutaneous abnormalities,
brittle hair
Xpa/jXpdXPCS/XPCS [9] NER/TCR Yes Cerebellar ataxia ;3 wk n.d.
Xpa/jCsb/ [20] NER/TCR Yes Cerebellar ataxia ;3 wk n.d.
Xpc/jCsa/, Xpc/jCsb/ [57] NER/TCR Yes Yes ;3 wk n.d.
Ercc1/ [25,30] NER/TCR; ICLR; telomere
maintenance[58]
Yes Ataxia ;3 wk Liver polyploidy; reduced
hematopoetic reserves [54]
Xpf/ [29] NER/TCR; ICLR; telomere
maintenance[58]
Yes n.d. ;3 wk Liver polyploidy
ICLR, interstrand cross-link repair; n.d., not determined; NER, nucleotide excision repair; TCR, transcription-coupled repair.
doi:10.1371/journal.pgen.0020192.t001
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proliferating primary cell cultures under conditions of
chronic or acute oxidative stress are related to the symptoms
common amongst the various progeroid syndromes listed in
Table 1.
Purkinje Cell Death Is a Late Event in Disease Progression
We next looked for differences in cell death or prolifer-
ation in vivo using one of the severe progeroid NER
syndromes, XPCS/XPA, in comparison to single mutant
(XPCS and XPA) and heterozygous (control) littermates at
postnatal days 5, 12, and 15 coincident with growth
retardation and ataxia but prior to signs of weight loss or
morbidity. We focused on this double homozygous mutant
because of the 100% penetrance of mortality around weaning
(Table 1). We ﬁrst examined cerebellar Purkinje neurons, one
of the few cell types consistently affected in severe progeroid
NER syndromes as reported for XPG, CSB/XPA, and XPCS/
XPA (Table 1). Despite disturbed gait and balance problems
consistent with cerebellar ataxia, CH/XPA mice showed no
detectable degeneration or loss of Purkinje neurons or
abnormalities in cerebellar morphology upon sacriﬁce at
the age of 5.5 mo (Figure 3A). Similarly, Purkinje neurons
were morphologically intact in all mutant and control XPD/
XPA animals at postnatal day 15 (Figure 3B). These results
were unexpected based on the almost complete loss of
Purkinje cells by postnatal day 20 in XPCS/XPA mice [9] as
well as XPG mice [28].
Except for cellular loss in the cerebellum very late in
disease progression, gross pathological analysis of double
Figure 1. Compound Heterozygosity at the Xpd Locus Partially Rescues Severe Progeroid NER Syndrome
(A) Growth curves of individual CH/XPA and control XPA animals from a representative litter.
(B) Food intake of CH/XPA animals versus XPA littermate controls (42 d old) and 25-d-old controls expressed per gram body weight. Asterisks indicate
statistical significance (p , 0.001) versus 42-d-old controls; error bars indicate standard error of the mean (SEM).
(C) Photographs of male littermate CH/XPA and control XPA mice over 5.5 mo.
(D) Kaplan-Meier survival curve of CH/XPA and littermate control XPA mice.
doi:10.1371/journal.pgen.0020192.g001
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mutant XPCS/XPA mice did not reveal overt defects in any
other major organ system investigated, similar to reports in
TTD/XPA and CSB/XPA mice [20,21]. Furthermore, we failed
to observe polyploidization of liver nuclei (Figure 3B) as in
Ercc1/ and Xpf/mice [25,29,30]. Cellular proliferation, as
measured by BrdU incorporation and Ki67 and PCNA
immunohistochemistry, in 5- and 12-d-old mice did not
reveal evident genotype-speciﬁc differences in the number of
replicating cells in the intestine, liver, kidney, heart, or lung
(unpublished data). Nor did we ﬁnd evidence of increased cell
death/apoptosis in hematoxylin-and-eosin- or TUNEL-
stained sections of various organs or following sensitive
ligation-mediated PCR-based analysis of DNA from organs
including liver, cerebellum, heart, and eye (Figure 3C and
unpublished data). Taken together, these in vitro and in vivo
data support neither a vicious cycle of cell death and
proliferative exhaustion nor a general cell-autonomous
proliferative defect per se as causative of the cachectic
dwarﬁsm and failure to thrive in the developmental period
that precedes severe pathology and death before weaning in
most progeroid NER mice.
Symptoms of Progeroid NER Syndrome Resemble Those
of Long-Lived Dwarfism and Calorie Restriction
We next looked for parameters that were partially rescued
by Xpd compound heterozygosity in CH/XPA mice compared
to XPCS/XPA mice in order to elucidate those parameters
that are important in disease etiology. We focused initially on
metabolic parameters including body weight, temperature,
and blood glucose in anesthetized mice. As shown in Figure
4A, signiﬁcant differences between mutants and controls
were observed in body weight, temperature, and blood
glucose in anesthetized mice upon sacriﬁce at postnatal day
15. Interestingly, however, these differences did not reach
statistical signiﬁcance between XPCS/XPA and CH/XPA
animals despite the large difference in lifespan.
Growth retardation, hypothermia, hypoglycemia (Figure
4A), and reduced body mass despite normal to increased food
intake per gram body weight (Figure 1B) are phenotypes
shared by long-lived mice with defects in growth hormone
(GH) signaling, including GH-deﬁcient Ames and Snell dwarfs
and GH-resistant GH receptor (GHR) knock-out (GHR-KO)
mice [31,32]. GH mediates its effects largely through the
increased secretion of insulin-like growth factor 1 (IGF-1) in
target tissues including the liver. To determine the status of
the GH/IGF-1 axis in progeroid NER syndrome, we measured
total IGF-1 in serum of postnatal day 15 animals (Figure 4B).
Compared to normally sized XPA animals, serum IGF-1 was
reduced in both XPCS/XPA and CH/XPA pups, although only
to a level of statistical signiﬁcance in XPCS/XPA animals (p ,
0.05). IGF-1 mRNA from liver, the major source of circulating
IGF-1, was signiﬁcantly reduced in both (Figure 4C, p , 0.05).
As a control, relative abundance of IGF-1 and a number of
other mRNAs in single mutant XPA, XPCS, and TTD livers
was not signiﬁcantly different from heterozygous controls
(unpublished data).
We next measured GH in the serum (Figure 4B). Despite
considerable interanimal variation, likely due to the pulsatile
nature of GH secretion from the pituitary [33], levels were in
the range of control XPA animals independent of genotype.
Thus, dwarﬁsm in NER progeria is not likely a primary
pituitary defect as in Ames and Snell dwarf mice, in which the
anterior pituitary fails to develop properly [34]. Consistent
with this, no histological or functional differences were
detected in the pituitary gland of another progeroid NER
mutant, CSB/XPA [35]. GH insensitivity, as in GHR-KO mice,
can also cause dwarﬁsm [36,37] even in the presence of excess
GH. Indeed, liver GHR mRNA abundance was signiﬁcantly
reduced in both XPCS/XPA and CH/XPA pups. Despite a
range of expression levels, maintenance of the strong
correlation between GHR and IGF-1 mRNA in individual
CH/XPA (r ¼ 0.84, n ¼ 12) and XPCS/XPA (r ¼ 0.76, n ¼ 8)
animals relative to control XPA animals (r ¼ 0.96, n ¼ 12)
suggests that coordinated transcriptional regulation is intact
in progeroid NER syndrome (Figure 4C, inset) and that GHR
mRNA levels are a relevant indicator of GHR protein
function.
Calorie restriction and GH deﬁciency/insensitivity both
result in hypoglycemia and hypoinsulinemia. Increased
sensitivity to the effects of insulin is thought to underlie the
low blood sugar and may also be a key to extended longevity
[31]. We measured serum insulin from day 15 animals and
found, similar to dwarves and calorie-restricted animals, no
evidence of hyperinsulinemia as a cause of hypoglycemia
(Figure 4B). IGF-1, IGF-1 binding protein 3 (IGF-BP3, also
known as GH-dependent binding protein), and acid-labile
subunit (ALS) form a ternary complex in the serum and are
all reduced in GH insensitivity disorders in proportion to the
severity of GH resistance [38]. In XPCS/XPA and CH/XPA
animals, liver IGF-BP3 and ALS mRNA levels were reduced in
addition to that of IGF-1, although the reduction in ALS
expression in CH/XPA did not meet the criteria for statistical
signiﬁcance (Figure 4C and unpublished data). Other key
genes involved in postnatal growth via the somatotroph axis,
Figure 2. Normal Proliferation of Progeroid NER Primary Cells upon Chronic and Acute Oxidative Stress In Vitro
(A–C) Serial passaging of MEFs from individual litters at 3% (filled symbols) versus 20% (open symbols) oxygen tension. Lines are compiled from the
indicated number of fibroblast cultures derived from single embryos and plotted as the log of the cumulative cell number over time; error bars indicate
SEM. Insets are the same data plotted to indicate the rate of growth; an average daily population doubling (PDL) of one indicates that the cells divide on
average once a day. (A) Black diamonds, control (n¼ 3); blue triangles, XPA (n¼ 1); grey squares, XPCS (n¼ 2); orange circles, XPCS/XPA (n¼ 2). (B) Blue
triangles, XPA (n¼ 4); orange circles, TTD/XPA (n¼ 2). (C) Black diamonds, control (n¼ 1); blue triangles, XPA (n¼ 2); grey squares, CSB (n¼ 2); orange
circles, CSB/XPA (n¼ 3).
(D) Serial passaging of mouse dermal fibroblasts prepared from tails of 10-wk-old animals at 3% (filled symbols) versus 20% (open symbols) oxygen
tension. Lines are compiled from the indicated number of fibroblast cultures derived from single animals and plotted as the log of the cumulative cell
number over time; error bars indicate SEM.
(E and F) Serial passaging of erythroblasts prepared from embryonic day 12.5 embryos from a representative litter. (E) Blue squares, control (n ¼ 5);
orange diamonds, CH/XPA (n¼ 4). (F) Black diamonds, control (n¼ 2); blue triangles, XPA (n¼ 3); grey squares, CSB (n¼ 1); orange circles, CSB/XPA (n¼
2).
(G) Proliferative capacity upon acute treatment with paraquat, ionizing radiation, tert-butylhydroperoxide (tBHP), and UV-C as indicated is expressed as
a percentage of growth of the untreated samples. Black diamonds, control (n¼ 3); blue triangles, XPA (n¼ 1); grey squares, XPCS (n¼ 2); orange circles,
XPCS/XPA (n ¼ 2); error bars indicate SEM.
doi:10.1371/journal.pgen.0020192.g002
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including deiodinase 1 (DIO1), which activates thyroid
hormone precursor, and the prolactin hormone receptor,
were signiﬁcantly reduced as well (Figure 4C). Within this
signature group of ﬁve somatotroph axis genes, mRNA
expression levels were signiﬁcantly different not only
between NER progeroid animals and controls, but also
between XPCS/XPA and CH/XPA animals; in each case,
downregulation was more severe in XPCS/XPA animals. Thus,
on the level of gene expression, downregulation of the
somatotropic GH/IGF-1 axis correlated with the severity of
NER progeria.
IGF-1, ALS, and prolactin receptor are three of a
surprisingly limited number of liver transcripts reported to
be altered in the long-lived GHR-KO dwarf (only ten genes at
a signiﬁcance of p , 0.001), while in Snell dwarf mice and
calorie-restricted mice, hundreds of liver transcripts are
differentially expressed using the same experimental plat-
form and statistical criteria [39]. From this list of ten
transcripts, we additionally tested IGF-BP2, ﬂavin-containing
monoxygenase 3 (FMO3), and apolipoprotein A-IV (APOAIV)
expression. Circulating concentrations of IGF-BP2 are known
to be inversely related to GH status [38] and were signiﬁcantly
upregulated in progeroid NER mice, further underlining the
downregulation of the somatotropic axis. FMO3, which is
involved in the oxidative breakdown of xenobiotic com-
pounds and downregulated in GHR-KO mice, was also
downregulated in progeroid NER mice. Finally, APOAIV
mRNA, encoding a protein involved in serum lipid transport
that is ;10-fold reduced in GHR-KO mice but 4- to 5-fold
increased upon 24–48 h of starvation [40], was 3- to 6-fold
increased in NER-deﬁcient mice. In conclusion, many but not
all characteristics of both CH/XPA and XPCS/XPA mice
resembled those of either calorie restriction or genetic
dwarﬁsm.
An Adaptive Response to Stress in Progeroid NER
Syndrome
In genetic dwarﬁsm, differences in serum IGF-1 and glucose
metabolism are caused by congenital, irreversible defects in
components of the postnatal growth axis itself. In calorie-
restricted animals, these differences are reversible and
represent an adaptive response to the stress of nutritional
deprivation.We followed blood glucose and serum IGF-1 levels
in CH/XPA mice over their lifespan to see if the phenotypic
overlap with dwarf and calorie-restricted animals was more a
constitutive defect or an adaptive response. At 10 wk of age,
blood glucose and serum IGF-1 levels were normal in CH/XPA
animals relative to WT and XPA controls (Figure 5). This
strongly suggests that the reduction of these components
during early postnatal development (Figure 4) represents an
adaptive response rather than a constitutive defect. At the end
of their lives, IGF-1 levels remained within the normal range,
while blood glucose levels once again fell signiﬁcantly below
controlWT and XPA levels. Low serum glucose levels were also
observed in the long-term survivors of a cohort of WT mice at
the end of their lives (approximately 2 y; Figure 5).
Is Somatotroph Axis Dampening Common to Progeroid
Genome Instability Disorders?
Cachectic dwarﬁsm is common in mouse models of genome
instability with segmental progeria, and has been attributed
in many cases to cell-autonomous proliferative defects
(premature senescence) as observed in cultured MEFs [3].
We next asked whether the dampening of the somatotroph
axis observed here in progeroid NER disorder is also found in
cachectic dwarﬁsm caused by a different primary DNA repair
defect. Ku80/ mice, which are defective in the repair of
double-strand DNA breaks via the nonhomologous endjoin-
ing (NHEJ) pathway, are smaller than control littermates from
embryonic day 17.5 on [41] and display multiple symptoms of
Figure 3. Proliferation and Cell Death Do Not Correlate with Onset or
Severity of Progeroid NER Syndrome
(A) Anti-calbindin staining (brown) of Purkinje neurons of 5.5-mo-old CH/
XPA and control XPA mice (magnification 1003).
(B) TUNEL staining (brown) with hematoxylin costain (blue) of liver
sections and anti-calbindin immunostaining (brown) with hematoxylin
costain (blue) of cerebellar sections of representative XPCS/XPA, CH/XPA,
and control XPA mice at 15 d of age (magnification 4003).
(C) Ligation-mediated PCR-based analysis of apoptosis in liver, cerebel-
lum, heart, and eye of postnatal day 5 (d5) and day 12 (d12) control (n¼
2–3), XPA (n¼3), XPCS (n¼3), and XPA/XPCS (n¼ 3–4) mice. The relative
amount of laddered PCR products representing apoptosis is presented in
arbitrary units on the y-axis; error bars indicate SEM.
doi:10.1371/journal.pgen.0020192.g003
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premature senescence including kyphosis, atrophic skin,
hepatocellular degeneration, and reduced lifespan due to
cancer and sepsis [42]. We looked at blood glucose and serum
IGF-1 levels in 2-wk-old animals and found no differences
between Ku80/ and WT or heterozygous littermate control
mice (Figure 6A). Next, we analyzed liver mRNA expression of
signature somatotroph axis genes in Ku80/ mice versus
littermate controls using quantitative real-time PCR, the
method found above to be most sensitive at identifying subtle
differences between progeroid NER mice. Despite having
50%–60% reduced weight relative to littermate controls,
Ku80/ mice did not display evidence of somatotropic axis
dampening as observed in progeroid NER mice of the same
age (Figure 6B). Nor was involvement of long-lived dwarf
GHR-KO signature genes such as ApoAIV detected. We also
found no evidence of somatotroph dampening in Ku80/
mice at 10 wk of age, when the activity of this axis should be
near its peak. As a control for the ability to detect
somatotropic axis dampening in 10-wk-old mice, we com-
pared them to older animals (;1 y of age) from the same
animal facility and observed the expected age-related
reduction in transcript abundance of somatotroph axis genes
including those encoding IGF-1 and DIO1. In conclusion,
unlike in NER progeria, we found no evidence of reduced
GH/IGF-1 signaling contributing to cachectic dwarﬁsm in
Ku80/ mice.
Discussion
We describe a new mouse model of progeroid NER
syndrome created by combining two different mutant Xpd
alleles in an Xpa/ background. A major beneﬁt of this model
over existing models (Table 1) is its ability to survive weaning
with high penetrance and its having a lifespan proportional
to relevant progeroid NER disorders including CS. Further-
more, it is simpler than XPG, XPF, and ERCC1 models that
additionally have profound cell-autonomous proliferative
defects. Using this model we found evidence for an adaptive
response to genome instability during postnatal development
involving dampening of the somatotropic GH/IGF-1 axis and
perturbation of glucose homeostasis. This response appears
so far speciﬁc to excision repair disorders, as it was not
Figure 4. Perturbation of GH/IGF-1 Axis Correlates with Severity of NER Progeria
(A) Body weight, temperature, and whole blood glucose of anesthetized WT control (n¼ 4, black); single mutant XPA (n¼ 23, blue) and XPCS (n¼ 6,
grey); and double mutant XPCS/XPA (n¼ 6, orange) and CH/XPA (n¼13, beige) animals relative to WT controls. Asterisks indicate statistical significance
versus WT controls (**, p , 0.01); error bars indicate SEM.
(B) Serum IGF-1, GH, and insulin as determined by ELISA in XPCS/XPA (n ¼ 5) and CH/XPA (n ¼ 7) relative to XPA (n ¼ 6) animals. Asterisk indicates
statistical significance versus XPA controls (*, p , 0.05); error bars indicate SEM.
(C) Abundance of liver mRNAs encoding IGF-1, GHR, IGF-BP3, DIO1, prolactin receptor (PRLR), FMO3, IGF-BP2, and APOAIV in XPCS/XPA (n¼ 8) and CH/
XPA (n¼12) relative to XPA (n¼12) mice as determined by quantitative real-time PCR. Asterisks indicate statistical significance versus XPA controls (*, p
, 0.05; **, p , 0.01); pound signs indicate statistical significance between XPCS/XPA and CH/XPA (#, p , 0.05; ##, p , 0.01); error bars indicate SEM.
Inset: correlation between relative IGF-1 and GHR mRNA expression values in individual animals; correlation coefficients per group: XPA, 0.96 (blue
diamonds); XPCS/XPA, 0.76 (orange circles); CH/XPA, 0.84 (yellow squares); overall, 0.92.
doi:10.1371/journal.pgen.0020192.g004
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observed in NHEJ-deﬁcient mice despite cachectic dwarﬁsm
and several progeroid features.
Uncoupling of Dwarfism and Progeria from Premature
Fibroblast Senescence in Progeroid NER Syndrome
There is a strong correlation between genomic instability
disorders with symptoms of progeria and premature sen-
escence of the corresponding cultured ﬁbroblasts, for
example, in Werner syndrome, Hutchinson-Gilford progeria,
and ataxia telangiectasia in humans [43], and BUB1, PASG,
DNA-PK, ERCC1, and KU80 mutants in mouse [3]. As a result,
cell-autonomous proliferative defects are generally regarded
as strong candidates underlying progeroid phenotypes,
including cachectic dwarﬁsm [3,41]. Mechanistically, this
may be due to not only reduced proliferative capacity per
se but also altered characteristics of senescent cells such as
secretion of inﬂammatory cytokines and extracellular matrix-
degrading enzymes [44]. Here, in related NER progerias (CH/
XPA, XPCS/XPA, TTD/XPA, and CSB/XPA), we demonstrated
that cell-autonomous proliferative defects as observed in two
different primary cell types, ﬁbroblasts and erythroblasts, are
not an absolute prerequisite for postnatal growth retardation
or progeria. This makes these NER-associated progerias
exceptional amongst mouse progeroid syndromes caused by
genome instability. Consistent with these ﬁndings in mice, CS
and TTD are peculiar amongst human progerias not only in
their lack of cancer predisposition but also in the failure of
cells to undergo premature senescence in culture [43]. Taken
together, these data suggest that defects particularly in
transcription-coupled NER are not growth limiting in
proliferating cells. This may be due to their ability to repair
(or tolerate) DNA damage by a variety of replication-
dependent, NER-independent mechanisms. In contrast, non-
dividing postmitotic cells such as neurons may be at greater
risk for the effects of transcription-coupled NER deﬁciencies
precisely because they do not have the opportunity to ‘‘clean’’
damaged genes or dilute the damage by DNA replication. At
the same time, neurons appear to downregulate their ability
to repair lesions via the global genome NER pathway [45].
Instead of revealing any cell-autonomous proliferative
defect, our data demonstrate dampening of the postnatal
GH/IGF-1 axis, making this a much more likely explanation
underlying reduced postnatal growth and small size. The
inability to detect gross differences in cell death or
proliferation in vivo except in speciﬁc cell types (i.e.,
cerebellar granular neurons [20]) or at the end stage of
disease (i.e., cerebellar Purkinje loss [9]) does not rule out the
contribution of small but signiﬁcant differences in the
number of proliferating or dying cells due to a lack of growth
and survival signals. Such differences are likely to be found in
speciﬁc cell compartments, such as slowly cycling (label-
retaining) cells of the germinal layer or chondrocytes in the
proliferative zone of the growth plate responsible for
longitudinal bone growth, which are stimulated by GH and
IGF-1, respectively [46].
Perturbation of Somatotropic GH/IGF-1 Axis and Glucose
Homeostasis: Constitutive Defect or Adaptive Response?
We observed a number of similarities of progeroid NER
mice with long-lived dwarf and calorie-restricted mice,
including small size, hypoglycemia, and reduced serum IGF-
1, indicative of dampening of the postnatal GH/IGF-1 growth
axis. In a number of model organisms including worms and
mice, suppression of the GH/IGF-1 axis is associated with
increased stress resistance and extended longevity [31].
Reduced serum IGF-1 can be caused by genetic defects in
structural components of the somatotropic axis itself (Ames
and Snell dwarfs and GHR-KO mice) or by an adaptive
response to environmental cues such as starvation or calorie
restriction. For example, Ames and Snell dwarf mice suffer
congenital hypopituitarism and lack a number of pituitary
hormones including GH from birth. Upon dietary restriction,
the only intervention known to extend lifespan in mammals,
reduced blood glucose and IGF-1 appear to be key compo-
nents of an adaptive response to stress [47,48] and are entirely
reversible. The apparent logic behind this reversible response
is to shift the metabolism away from energy consumption
directed at growth or reproduction toward energy conserva-
tion and somatic maintenance with a concomitant increase in
the ability of cells to cope with stress, with an overall aim of
enhancing survival until favorable conditions return.
In CH/XPA mice, blood glucose and serum IGF-1 were
reduced relative to controls at 2 wk of age but returned to
normal by 10 wk of age. These data strongly argue against any
structural defect in the components of the somatotropic axis
or glucose homeostasis itself. This also makes what is
happening in CH/XPA mice potentially quite different from
what has been proposed for progeroid SIRT6/ mice. Based
on these animals’ low blood glucose and serum IGF-1, failure
to thrive, and death with high penetrance before weaning
[49], the authors proposed an important role for SIRT6 in
maintaining organismal homeostasis, in addition to a role in
DNA repair via the base excision repair (BER) pathway. In
Figure 5. Kinetics of Blood Glucose and Serum IGF-1 Levels throughout
the Life of CH/XPA Mice
Longitudinal measurements of (A) blood glucose and (B) serum IGF-1 in
CH/XPA versus XPA and WT control mice. Error bars indicate SEM; 5–15
animals were used per genotype per timepoint. p-Value indicates the
significance of the difference relative to WT at that timepoint.
doi:10.1371/journal.pgen.0020192.g005
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CH/XPA mice, we believe that the reduced blood sugar and
serum IGF-1 during early postnatal development are compo-
nents of an adaptive response to some form of stress
experienced during this period before weaning. Although
the nature of this stress is unknown, it appears to be initiated
soon after birth and may involve the dramatic transition from
prenatal to postnatal environment, including a different
oxygen concentration and a switch in energy acquisition
source from the mother’s blood via her bloodstream to the
mother’s milk via the pup’s own digestive system, combined
with a period of rapid growth.
Interestingly, although serum IGF-1 levels remained in the
normal range at least some time before the death of the CH/
XPA animals, blood glucose levels dropped signiﬁcantly
below those of age-matched controls, indicating that low
IGF-1 levels do not always precede low glucose. We also
observed reduced glucose levels in 15 of the oldest survivors
of a longevity cohort of WT mice. Recently it was reported
that senescent terminal weight loss in rats correlated with
extended longevity [50]. It is therefore tempting to speculate
that reduced size and decreased blood glucose are compo-
nents of an adaptive response intended to extend longevity in
both normal and some forms of pathological aging rather
than the unintended consequences of random degenerative
processes.
Differences between progeroid NER mice and long-lived
dwarf mice, on the other hand, may be better explained by
defects in the transcription function of the transcription
factor II H complex to which XPD belongs. For example,
altered fat metabolism in CH/XPA mice may be related to
reported defects in the activation of peroxisome proliferator-
activated receptors implicated in lipid metabolism [51].
Paradox of IGF-1 Reduction: Extended Versus Shortened
Lifespan
Although reduced serum IGF-1 on its own does not result
in dwarﬁsm or extended longevity in mice (liver IGF-1 knock-
out; [52]), it correlates with both in most reported cases.
Comparative liver transcriptome analyses of long-lived mice
with dwarﬁsm versus calorie restriction also point to IGF-1 as
one of the few consistent predictors of extended longevity
[39]. If reduced IGF-1 mRNA correlates with increased
Figure 6. Analysis of Blood Glucose, Serum IGF-1, and Liver Gene Expression Profiling in NHEJ-Deficient Ku80/ Mice
(A) Glucose and IGF-1 levels in the blood serum of 2-wk-old Ku80/ versus WT or heterozygous littermate controls. Error bars indicate SEM; six animals
were used per group.
(B) Abundance of liver mRNAs encoding IGF-1, GHR, IGF-BP3, DIO1, prolactin receptor (PRLR), FMO3, IGF-BP2, and APOAIV) in 2-wk-old Ku80/ (n¼ 6)
versus 2-wk-old WT or heterozygous littermate controls (n¼ 6); and both 10-wk-old Ku80/ (n¼ 4) and ;1-y-old versus 10-wk-old controls (n¼ 5) as
determined by quantitative real-time PCR. Error bars indicate SEM between experiments.
doi:10.1371/journal.pgen.0020192.g006
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longevity, why were liver IGF-1 mRNA levels observed here
lowest in XPCS/XPA animals with the shortest lifespan and
intermediate in CH/XPA mice with intermediate longevity?
Our data demonstrate that IGF-1 dampening is reversible (at
least in the CH/XPA mice) and thus most likely an adaptive
response to genotoxic stress. When considering the beneﬁts
of reduced IGF-1, one must also in this case consider the
magnitude of the stress that triggers this response. At some
level of damage, this stress may overrule the efﬁcacy of the
response even at its maximal beneﬁcial level. According to
this interpretation, the magnitude of the dampening of the
postnatal growth axis does not correlate directly to lifespan
extension, but to the magnitude of the perceived stress, be it
starvation or genome instability, and is independent of
whether that stress response is successful in extending
longevity (Figure 7A). Thus in XPCS/XPA and TTD/XPA
mice, this results in death before weaning with high
penetrance despite the maximal stress response; compound
heterozygosity at the Xpd locus, which partially complements
this defect, results in a less robust stress response because of
less or slower damage accumulation, resulting in longer
lifespan. Whether or not this response is adaptive or
maladaptive and what actually triggers it (i.e., central nervous
system dysfunction or malnutrition) remain important
questions for future research.
Uncoupling of Postnatal Growth Axis Dampening from
Dwarfism in Progeroid Genome Instability Disorders
In contrast to certain progeroid NER disorders, cultured
Ku80/ ﬁbroblasts display cell-autonomous proliferative
defects [26]. Furthermore, Ku80/ dwarﬁsm is not exclusively
postnatal (animals are already smaller at birth [41]), and we
found no evidence of perturbation of the GH/IGF-1 postnatal
growth axis at 2 wk, as in progeroid NER disorder, or at 10
wk, near the peak of somatotroph axis activity. This suggests a
model in which cachectic dwarﬁsm and progeria can be
caused by at least two fundamentally distinct mechanisms:
perturbation of postnatal growth signaling independent of
cell-autonomous proliferative defects, as in NER progeria, or
cell-autonomous proliferative defects without perturbation
of the somatotroph axis, as in KU80 deﬁciency. Because these
two scenarios are not necessarily mutually exclusive (for
example, Ercc1/ and Xpg/ mice display symptoms of NER
progeria [Table 1] but also have cell-autonomous prolifer-
ative defects; SIRT6/ mice with a reported BER deﬁciency
also display cell-autonomous proliferative defects in addition
to reduced serum IGF-1), dwarﬁsm can likely result from
combinations of both. In Figure 7B, we summarize how
defects in growth factor environment and cell-autonomous
proliferative capacity may independently or together pro-
duce the symptoms of segmental progeria due to NER
dysfunction or other defects in genome maintenance.
Conclusions
Taken together, these data reveal perturbation of the GH/
IGF-1 axis as a novel mechanism underlying the common
symptoms of progeroid NER syndromes. Downregulation of
IGF-1 may thus be part of a general stress response activated
not only upon conditions such as food scarcity but also in
response to the accumulation of certain types of DNA
damage via congenital repair defects and possibly natural
aging. In support of this interpretation, end-of-life pathology
in TTD mice is consistent with both segmental accelerated
aging (e.g., increased lipofuscin accumulation in the liver) and
calorie restriction (e.g., reduced incidence of pituitary
adenomas) [53]; TTD liver gene expression also resembled
Figure 7. Model for GH/IGF-1 Axis and Cell Proliferation Involvement in Segmental Progeroid Genome Instability Disorders
(A) Inverse correlation between IGF-1 and lifespan in progeroid NER syndrome. Decreased IGF-1 signaling usually correlates positively with increased
longevity; in XPD/XPA mutants lower serum IGF-1 (y-axis on the left) instead correlates inversely with lifespan. To explain this apparent paradox, we
interpret serum IGF-1 levels as indicative of the magnitude of the perceived genotoxic stress (red arrows, y-axis on the right). This genotoxic stress may
overrule the efficacy of reduced IGF-1 in XPCS/XPA and TTD/XPA animals, while in CH/XPA animals compound heterozygosity partially complements
the defect, relieving genotoxic stress and reducing the corresponding stress response.
(B) Model for the differential contribution of cell-autonomous proliferative defects and systemic growth axis perturbation to progeria in genome
instability disorders. Growth signals from the GH/IGF-1 somatotropic axis are dampened in progeroid NER syndrome (small red arrow), leading to
postnatal growth deficiency; cells removed from this environment and provided adequate growth signals proliferate normally (dotted arrow represents
WT proliferative capacity). In other segmental progerias, such as SIRT6 deficiency with a reported defect in BER, both appear to be affected. Alternately,
cellular proliferation can be affected without apparent involvement of the somatotropic axis as in NHEJ-deficient Ku80/ mice.
doi:10.1371/journal.pgen.0020192.g007
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that of long-lived dwarf mice (Y. Suh, J. Y. Park, M. O. Cho, S.
Leonard, B. Calder, unpublished data). Similarly, transcrip-
tome analysis of CSB/XPA livers revealed signiﬁcant down-
regulation of the somatotroph axis as well as upregulation of
antioxidant defense [35]. Finally, reduced serum IGF-1 and
glucose levels were observed in segmental progeroid SIRT6
knock-out mice, with a tentative link to a defect in DNA
repair via the BER pathway [49]. The relevance of these
ﬁndings from mouse models to the related human disorders
remains to be determined. Downregulation of neuroendo-
crine GH/IGF-1 signaling has not been a consistent ﬁnding in
CS or TTD patients, although the relative paucity of both
patients and data prevents ﬁrm conclusions from being
drawn [16–18]. However, as evidenced by the reduced cancer
incidence in hypopituitary dwarf mice [31], it is a plausible
mechanism contributing to the lack of cancer observed in
these individuals [16–18].
Materials and Methods
Mice. Xpa/, XpdTTD (XPDR722W) and XpdXPCS (XPDG602D) mice were
generated as described previously [9,10,23]. Mice were in a mixed
129OlajC57BL/6jFVB background. All experiments involving mice
were evaluated and approved by the National Committee for Genetic
Identiﬁcation of Organisms and the Animal Ethics Committee and
were conducted according to national and international guidelines.
Cells. Embryonic ﬁbroblasts from day 13.5 embryos were dispersed
by mechanical disruption with an Ultra-Turrax T25 Basic (Ika, http://
www.ika.net) and cultured in a 50:50 mix of DMEM:Ham’s F10
supplemented with 10% fetal bovine serum and antibiotics (pen/
strep) in a mixed gas incubator with 5% CO2 and 3% O2 (passage 0)
unless otherwise noted. For long-term proliferation assays, cells were
counted using a Coulter Multisizer Z2 (Beckman Coulter, http://www.
beckmancoulter.com) , seeded at 375,000 cells per 10-cm dish, and
cultured at both 3% and atmospheric oxygen tensions. For
subsequent passages, cells were trypsinized before they reached
;80% conﬂuence. For acute stress sensitivity assays, early passage
cells (passage 1–5) were plated in duplo in six-well plates at a density
of 20,000 cells per well and treated with the appropriate agent the
following day. Cells were counted 4–5 d after treatment using the
Multisizer Z2 and plotted as a percentage of the total number of cells
from the corresponding untreated cell line. Dermal ﬁbroblasts were
prepared from the isolated tail skin of euthanized animals. Following
mincing with a razor, tail skin was incubated overnight in a mixed gas
incubator with 5% CO2 and 3% O2 in DMEM supplemented with
20% fetal bovine serum and antibiotics and 40 mg/ml Type II
Collagenase (Invitrogen, http://www.invitrogen.com). The next day,
cells were resuspended, passaged through a 40-lm ﬁlter, washed, and
replated in medium without collagenase. Long-term proliferation
assays were performed as above except that cells were plated at a
slightly higher density (500,000 cells per 10-cm round bottom dish).
Erythroblast cultures were derived from fetal livers removed from
day 13.5 embryos. Progenitors were cultured as previously described
[54] under normoxic conditions.
Apoptosis. Apoptosis was measured by ligation-mediated PCR
using the Apo-Alert LM-PCR Ladder Assay Kit in combination with
Advantage cDNA Polymerase mix (both from Clontech, http://www.
clontech.com) according to the manufacturer’s instructions. TUNEL
assays were performed using the ApoTag Plus Peroxidase In Situ
Apoptosis Detection Kit (S7101, Chemicon International, http://www.
chemicon.com) according to the manufacturer’s instructions.
Immunohistochemistry. For histological examination, mouse
samples ﬁxed in formalin were embedded in parafﬁn, sectioned,
rehydrated, and stained with hematoxylin and eosin or monoclonal
antibodies against PCNA, Ki67, or calbindin and visualized based on
HRP-conjugated secondary antibodies. TUNEL staining was per-
formed using ApopTag Plus Peroxidase In Situ Apoptosis Detection
Kit (Chemicon International) according to the manufacturer’s
instructions.
Physiologic parameters. Food intake was measured by weighing
remaining dry food given to individually housed animals (three per
genotype) and the corresponding animals themselves each day over
the period of 4 d; the experiment was repeated twice with different
litters at different times. Body temperature was measured in animals
immediately following anesthetization with Isoﬂuran (Baxter, http://
www.baxter.com) by inserting a surgical thermometer into a small
hole cut in the abdominal cavity or into the rectum. Blood was
collected following decapitation. Glucose was measured in whole
blood using the Freestyle Mini blood glucose meter (Abbott
Laboratories, http://www.abbott.com) with a range of detection
between 1.1 and 27.8 mmol/l. Serum was prepared by low speed
centrifugation following clotting. Serum IGF-1, GH, and insulin
were measured by ELISA using Mouse/Rat IGF-I (DSL-10–2900), with
a range of detection between 50 and 3,500 ng/ml, and Mouse/Rat
GH (DSL-10–72100) with a range of detection between 1 and 100
ng/ml, both from Diagnostic Systems Laboratories (http://
www.dslabs.com), and Ultrasensitive Mouse Insulin ELISA (10-
1150-01), with a range of detection between 0.188 and 3.75 lg/l,
from Mercodia (http://www.mercodia.com), according to the manu-
facturer’s instructions.
Quantitative real-time PCR. Total RNA was extracted from the
liver using TRIzol reagent (Invitrogen) and oligodT or hexamer-
primed cDNA synthesized using SuperScript II (Invitrogen) according
to the manufacturer’s instructions. Quantitative real-time PCR was
performed using an Opticon2 DNA Engine and a MyIQ (Bio-Rad,
http://www.bio-rad.com) with SYBR Green incorporation. Relative
expression was calculated using the equation 1.8(DCt sample – DCt control)
[55]. Each sample was tested in duplo at least two times.
Supporting Information
Video S1. Progeroid Features of CH/XPA Mice
CH/XPA mice are shown relative to littermate controls at 2 mo of age
displaying unusual daytime eating behavior and abnormal clasping of
hind limbs in a tail-hanging test; and again at 5 mo of age displaying
disturbed gait, loss of balance, and kyphosis.
Found at doi:10.1371/journal.pgen.0020192.sv001 (3.0 MB WMV).
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